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Case Report
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Abstract
Lung cancer has been well documented to spread to bone and the axial skeleton after metastasis to adjacent organs. Bony
metastasis is not, however, the typical presenting manifestation. The differential diagnosis for a tissue mass on the skull
should warrant a workup for metastatic disease. Bony metastasis plays an important role in treatment and disease manage-
ment. We report an exceptionally rare case of stage IV lung adenocarcinoma that presented with a solitary skull metastasis
and a significant soft-tissue component. The lesion was treated by excision via craniotomy and subsequent medical man-
agement of the adenocarcinoma. This case illustrates a very rare presentation of lung adenocarcinoma and also represents
what the authors believe to be the first report of a solitary skull mass originating from a lung primary. We also present a
review of the literature surrounding bony metastasis to the skull and implications for patient care.
INTRODUCTION
Bony metastases are a common finding in numerous cancers,
particularly breast, prostate and lung. Lung cancer specifically
is associated with bony metastases in up to 36% of patients on
post-mortem studies [1]. Similarly, bony metastases are the
most common cause of cancer-related pain and can be utilized
as a marker for monitoring disease progression and prognosti-
cation [1, 2]. It is the pain, often associated with pathological
fracture that often leads patients to seek medical treatment in
the case of bony metastases. Generally a bony metastasis by
itself is unlikely to lead to medical presentation and eventual
diagnosis of the primary malignancy. This is especially true
when the metastasis is located within the skull and can be mis-
taken for soft tissue swelling from injury. In fact, Sugiura et al. [2]
identified skull metastases in only 3% of skeletal metastases from
lung cancer. Likewise, no evidence in the literature describes a
solitary skull metastasis as the primary presenting feature for
lung adenocarcinoma.
In this report, we present the case of a 69-year-old female
that presented to the clinic complaining of an expanding soft-
tissue mass on her left frontoparietal skull associated with
facial pain. The patient received a complete oncological
workup and surgical excision of the mass. The excised mass
was pathologically consistent with metastatic lung adenocar-
cinoma. This is the first such presentation of primary lung
adenocarcinoma metastasis to the skull in the literature and
dictates caution and careful clinical consideration when
evaluating expanding lesions on the skull. This is especially
important for lung adenocarcinoma where early diagnosis can
affect overall prognosis.
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CASE REPORT
The patient, a 69-year-old white female, was referred by her
primary care provider to a plastic surgeon at United Hospital
Center for treatment of what was believed to be a soft-tissue
mass of the left forehead (frontoparietal region) (Fig. 1). The
mass had increased in size for the prior 2–3 months and
resulted in a radiating pain down the left side of the face. The
mass was non-mobile and tender to touch. Prior to this referral,
the patient was relatively healthy with a past medical history
significant for arthritis, depression and hypertension. Her surgi-
cal history was positive for tonsillectomy and partial hysterec-
tomy. Her social history is significant for a 60-pack-year
smoking history (1.5 packs/day for 40 years). The soft tissue
mass had been managed conservatively for presumptive der-
matological infection (subcutaneous/sebaceous cyst) with a 10-
day course of levofloxacin 500mg tablets taken once daily. The
tablets, however, provided no symptomatic relief. Imaging
(computed tomography (CT)) of the maxillofacial area and brain
without contrast was obtained in addition to plain films of the
skull. These images revealed a lytic lesion of the skull in the
left frontopartietal region (Fig. 2). The patient was referred to
the oncology department for further workup.
The primary differential considered by the oncologist based
on the significant smoking history was metastatic neoplasm
versus multiple myeloma. Therefore, a CT of the chest/abdo-
men/pelvis was ordered as well as blood work (CBC, chemistry,
molecular monoclonal gammopathy workup). Imaging demon-
strated one speculated right hilar nodule concerning for neo-
plasm in the lung that was measured at 2.4 × 2.4 cm. No other
evidence of metastatic disease was present within the chest,
abdomen or pelvis. Workup for multiple myeloma was negative
based on the results of serum protein electrophoresis and
immunofixation. The patient was subsequently referred for
bronchoscopy and to neurosurgery for biopsy of the skull mass.
Neurosurgical examination revealed grossly intact cranial
nerves with no upper motor neuron signs or motor weakness
in all extremities. Sensation was also intact bilaterally. Due to
slight effacement of the subarachnoid space and for surgical
planning, MRI brain was ordered. MRI demonstrated a 2.8-cm
lesion that extended from the subcutaneous fat through the
inner and the outer table of the left frontal bone with slight
encroachment on the dural space. Minimal mass effect was
observed with only slight asymmetry of the fluid signal in the
frontoparietal region on the left (Fig. 3). At this time, the deci-
sion was made to proceed with a surgical excision. No apparent
invasion of the dura or brain parenchyma was noted, thereby
satisfying therapeutic and diagnostic aims. The lesion was
Figure 1: Schematic representation of the lesion location. The soft-tissue com-
ponent was measured at a diameter of 3.3 cm and located on the left forehead
near the hairline.
Figure 2: CT soft tissue demonstrating the presence of a lytic lesion in the left
frontopartietal region. (A) Axial cut, (B) coronal cut and (C) sagittal cut.
Figure 3: MR imaging redemonstrating the presence of a left frontoparietal
mass that does not appear to invade the dura. (A) Sagittal T1, (B) axial T1, (C)
axial T1 with contrast, (D) axial T2, (E) axial FLAIR, (F) coronal pre-contrast and
(G) coronal post-contrast.
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excised successfully (3.5 × 3.5 × 1.5 cm) with no surgical compli-
cations. Histological analysis of the lesion revealed adenocar-
cinoma that was CK7 positive, CK20 negative and TTF-1
positive. These findings were consistent with a metastatic
adenocarcinoma from a lung primary. With stage IV adenocar-
cinoma, the patient was started on chemotherapy following
surgical excision and managed by the oncology service. Her
management included a full oncological workup complete with
full-body PET scan.
DISCUSSION
While the rate of bony metastases associated with lung cancer
is relatively high, estimated at ~36%, only 3% of these are gen-
erally found within the skull. The first presenting sign of lung
adenocarcinoma being skull metastasis is exceptionally rare
and has not been previously reported in the literature. This
case provides an example of such findings. This is in contrast
to other malignancies, such as hepatocellular carcinoma (HCC),
which has been widely reported to present as a solitary skull
metastsis [3]. Hepatic cholangiocarcinoma, in particular, is
exceptionally prone to metastasize to the skull [4]. Therefore, it
is clear for diagnostic, therapeutic and prognostic purposes
that a biopsy must be obtained, which was excisional in nature
in the reported case.
The route of metastasis in this case is not clear but possible
routes have been discussed at length in the literature and
include transmission frommandibular lymphatics. Once seeded,
the tumor develops a rich vasculature supply and spreads into
adjacent soft-tissue [5]. In rare cases, skull metastasis can lead
to epidural hematoma [6]. The important component for treat-
ment is TNM staging. CT scans have become the gold standard
for diagnosis and staging of lung adenocarcinoma [7]. Evidence
suggests that CT scan is even better than radionucleotide
imaging for skull metastasis [8]. With regard to treatment, the
initial extent of the disease dictates overall survival [9].
Clinical suspicion should be high when evaluating an isolated
soft-tissue lesion with skull penetration. Skull biopsy with
tumor excision followed by aggressive chemotherapy is often
required [10]. Sugiura et al. [2] found that in women with lung
adenocarcinoma and bony metastasis that early initiation of
systemic chemotherapy was associated with a good overall
survival and prognosis.
Based on the findings from this case, the authors recom-
mend a careful and thorough evaluation for any persistent
soft-tissue mass on the skull. Early diagnosis and treatment
can lead to good overall prognosis. Clinical suspicion should be
high for this potentially life-threatening disease.
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